Natural History and Treatment Outcomes of Congenital Thrombotic Thrombocytopenic Purpura: A Retrospective Longitudinal Cohort Study
Journal of Health Economics and Outcomes Research · 12.08.2026 · 13 (2)
DOI: 10.36469/001c.164543 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Health Economics and Outcomes Research, online erschienen am 12.08.2026. Verfasst von Paul Coppo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and National Reference Center for Thrombotic Microangiopathies Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris …. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Congenital thrombotic thrombocytopenic purpura (cTTP) is an ultra-rare, life-threatening thrombotic disorder. The real-world clinical trajectory and management of cTTP are not well defined.
Objectives
Describe patient characteristics, quantify the incidence and prevalence of clinical manifestations and disease-related complications, and describe treatment patterns and treatment-related outcomes of patients with cTTP.
Methods
In this retrospective, multinational, longitudinal cohort study, data were abstracted from the medical records of patients with severe hereditary ADAMTS13 deficiency (
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology and National Reference Center for Thrombotic Microangiopathies Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris and Sorbonne - Université (AP-HP.6), Paris, France.
- Université Paris Cité, Sorbonne Université, Inserm UMRS_1138, Centre de Recherche des Cordeliers, Paris, France.
- Department of Haematology University College London Hospital, Haematology Theme-NIHR UCLH/UCL BRC, London, UK.
- Department of Hematology and Central Hematology Laboratory Bern University Hospital, University of Bern, Bern, Switzerland.
- Department of Biological Hematology AP-HP.Nord, Lariboisière hospital, Paris, France.
- Takeda Development Center Americas, Inc., Cambridge, Massachusetts, USA.
ORCID-Profile: Paul Coppo, Marie Scully, Johanna A Kremer Hovinga, Bérangère S Joly, Agnès Veyradier, Ping Du, Hamid Ferdosi
Zitieren
APA
Coppo, P., Scully, M., Kremer Hovinga, J. A., Joly, B. S., Veyradier, A., Du, P., Patwari, P., Wang, L. T., Mellgård, B., Ferdosi, H., & Saad, R. (2026). Natural History and Treatment Outcomes of Congenital Thrombotic Thrombocytopenic Purpura: A Retrospective Longitudinal Cohort Study. Journal of Health Economics and Outcomes Research, 13(2). https://doi.org/10.36469/001c.164543
Vancouver
Coppo P, Scully M, Kremer Hovinga JA, Joly BS, Veyradier A, Du P, et al. Natural History and Treatment Outcomes of Congenital Thrombotic Thrombocytopenic Purpura: A Retrospective Longitudinal Cohort Study. Journal of Health Economics and Outcomes Research. 2026;13(2). doi:10.36469/001c.164543
BibTeX
@article{Coppo2026,
author = {Coppo, Paul and Scully, Marie and Kremer Hovinga, Johanna A and Joly, Bérangère S and Veyradier, Agnès and Du, Ping and Patwari, Parth and Wang, Linda T and Mellgård, Björn and Ferdosi, Hamid and Saad, Ragy},
title = {Natural History and Treatment Outcomes of Congenital Thrombotic Thrombocytopenic Purpura: A Retrospective Longitudinal Cohort Study},
journal = {Journal of Health Economics and Outcomes Research},
year = {2026},
volume = {13},
number = {2},
doi = {10.36469/001c.164543}
}
EUVIMED